financetom
Business
financetom
/
Business
/
Enservco Faces Delisting From NYSE Over Shareholders' Equity Requirement; Shares Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enservco Faces Delisting From NYSE Over Shareholders' Equity Requirement; Shares Fall
Jun 10, 2024 8:13 AM

10:53 AM EDT, 06/10/2024 (MT Newswires) -- Enservco ( ENSV ) said Monday that the New York Stock Exchange has decided to start proceedings to delist its shares from the exchange after the company failed to maintain a minimum of $6 million of shareholders' equity.

The firm said it plans to file an appeal and to submit a cure of its equity deficit to meet the stockholders' equity requirement.

Among the actions, Enservco ( ENSV ) said it has signed a terms sheet for a $10 million equity line of credit and is also exploring strategic initiatives to rationalize its assets. It added that Rich Murphy and Cross River Partners has converted its $1.2 million November 2022 convertible note and also $1.0 million of its September and October 2023 convertible notes into equity.

The shares were down about 25% in recent trading.

Price: 0.18, Change: -0.06, Percent Change: -25.63

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cleveland-Cliffs Swings to Q1 Adjusted Earnings, Revenue Drops -- Shares Decline After Hours
Cleveland-Cliffs Swings to Q1 Adjusted Earnings, Revenue Drops -- Shares Decline After Hours
Apr 22, 2024
04:44 PM EDT, 04/22/2024 (MT Newswires) -- Cleveland-Cliffs ( CLF ) reported Q1 adjusted earnings late Monday of $0.18 per diluted share, swing from a loss of $0.11 per share a year earlier. Analysts polled by Capital IQ expected earnings of $0.21 per share. Revenue for the quarter ended March 31 was $5.20 billion, down from $5.30 billion a year...
Medpace Q1 Earnings, Revenue Rise; Updates 2024 Guidance
Medpace Q1 Earnings, Revenue Rise; Updates 2024 Guidance
Apr 22, 2024
04:47 PM EDT, 04/22/2024 (MT Newswires) -- Medpace Holdings ( MEDP ) reported Q1 earnings late Monday of $3.20 per diluted share, up from $2.27 a year earlier. Four analysts polled by Capital IQ expected $2.47. Revenue for the quarter ended March 31 was $511 million, up from $434.1 million a year earlier. Analysts surveyed by Capital IQ expected $512...
Simpson Manufacturing Q1 EPS, Net Sales Decrease
Simpson Manufacturing Q1 EPS, Net Sales Decrease
Apr 22, 2024
04:47 PM EDT, 04/22/2024 (MT Newswires) -- Simpson Manufacturing ( SSD ) reported Q1 earnings late Monday of $1.77 per diluted share, down from $2.05 a year earlier. Three analysts polled by Capital IQ expected $1.92. Net sales for the quarter ended March 31 were $530.6 million, down from $534.4 million a year earlier. Four analysts surveyed by Capital IQ...
Vaxcyte Insider Sold Shares Worth $490,199, According to a Recent SEC Filing
Vaxcyte Insider Sold Shares Worth $490,199, According to a Recent SEC Filing
Apr 22, 2024
04:46 PM EDT, 04/22/2024 (MT Newswires) -- Andrew Guggenhime, President and CFO, on April 18, 2024, sold 8,000 shares in Vaxcyte ( PCVX ) for $490,199. Following the Form 4 filing with the SEC, Guggenhime has control over a total of 95,679 shares of the company, with 95,679 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649094/000141588924011322/xslF345X03/form4-04222024_080406.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved